https://medicaldialogues.in/news/industry/pharma/merck-announces-positive-results-from-phase-3-keynote-859-trial-of-keytruda-plus-chemotherapy-to-treat-patients-with-her2-negative-gastric-or-gej-adenocarcinoma-107365